Treatment of a patient with end-stage renal disease with Rituximab: pharmacokinetic evaluation suggests Rituximab is not eliminated by hemodialysis.

Abstract:

:The purpose of this study was to determine if therapeutic levels of Rituximab could be achieved in a patient with renal failure being dialyzed and if Rituximab is removed by hemodialysis. A 54-year-old man with low-grade lymphoma and renal failure on hemodialysis received 8 weekly treatments of Rituximab at 375 mg/M(2). Serum Rituximab levels were obtained before and after each treatment, before and after dialysis following each treatment, as well as in the dialysate fluid. The serum levels of Rituximab increased gradually with each treatment and were comparable to levels in patients with normal renal function. The postdialysis levels were higher than the predialysis levels as a consequence of hemo-concentration after dialysis. Rituximab was not detected in the dialysate fluid. The patient developed life-threatening hyperkalemia after the fourth treatment, which we believe occurred secondary to tumor lysis. Therapeutic levels of Rituximab may be maintained in patients undergoing dialysis. Rituximab is not eliminated by hemodialysis.

journal_name

Am J Hematol

authors

Jillella AP,Dainer PM,Kallab AM,Ustun C

doi

10.1002/ajh.10213

keywords:

subject

Has Abstract

pub_date

2002-11-01 00:00:00

pages

219-22

issue

3

eissn

0361-8609

issn

1096-8652

journal_volume

71

pub_type

杂志文章
  • Febrile transfusion reaction following initial transfusion in a man with immunoblastic lymphadenopathy and granulocyte autoantibodies.

    abstract::A 69-year-old man with immunoblastic lymphadenopathy and autoimmune hemolytic anemia who had no previous exposure to blood products developed a severe febrile nonhemolytic transfusion reaction following the initial infusion of packed red blood cells. The reaction recurred with transfusion of packed red blood cells, bu...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830140112

    authors: Barnes HM,Poon MC,Huang ST,Conrad ME,Lin J,McGowan EI

    更新日期:1983-02-01 00:00:00

  • Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.

    abstract::Although acute myeloid leukemia (AML) with t(8;21) belongs to the favorable risk AML subset, relapse incidence may reach 30% in those patients. RUNX1-RUNX1T1 fusion transcript is a well-established marker for minimal residual disease (MRD) monitoring. In this study, we investigated the feasibility and performances of ...

    journal_title:American journal of hematology

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/ajh.23696

    authors: Duployez N,Nibourel O,Marceau-Renaut A,Willekens C,Helevaut N,Caillault A,Villenet C,Celli-Lebras K,Boissel N,Jourdan E,Dombret H,Figeac M,Preudhomme C,Renneville A

    更新日期:2014-06-01 00:00:00

  • Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients.

    abstract::Chronic granulomatous disease (CGD) is an innate immunodeficiency with a genetic defect of the nicotinamide adenosine dinucleotide phosphate, reduced, oxidase components. This leads to decreased reactive oxygen species (ROS) production, which renders patients susceptible to life-threatening infections. Over the course...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24573

    authors: Wolach B,Gavrieli R,de Boer M,van Leeuwen K,Berger-Achituv S,Stauber T,Ben Ari J,Rottem M,Schlesinger Y,Grisaru-Soen G,Abuzaitoun O,Marcus N,Zion Garty B,Broides A,Levy J,Stepansky P,Etzioni A,Somech R,Roos D

    更新日期:2017-01-01 00:00:00

  • Juvenile features in adult-type chronic granulocytic leukemia.

    abstract::Philadelphia chromosome (Ph1) positive, or "adult-type," chronic granulocytic leukemia (CGL) differs in many clinical and laboratory aspects from PH1-negative, or "juvenile," CGL. Because of these differences, the disorders have been considered two distinct disease entities. We present a child with Ph1-positive CGL wh...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830160114

    authors: Gay JC,Dessypris EN,Roloff JS,Lukens JN

    更新日期:1984-01-01 00:00:00

  • Hemostatic molecular markers in nephrotic syndrome.

    abstract::Quantitative changes of hemostatic molecular markers were studied in patients with nephrotic syndrome. The plasma levels of fibrinopeptide A (FPA), thrombin-antithrombin III complex (TAT), products of thrombin activation, and fragment F1 + 2 (F1 + 2), a product of prothrombin activation, were measured by enzyme immuno...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830440411

    authors: Chen TY,Huang CC,Tsao CJ

    更新日期:1993-12-01 00:00:00

  • Disturbance of plasma and platelet thrombospondin levels in sickle cell disease.

    abstract::Thrombospondin (TSP), a large protein found in platelet alpha-granules (as TSP-1), mediates adhesion of sickle reticulocytes to cultured vascular endothelium. To further explore the physiologic relevance of this observation, we have measured plasma TSP levels and platelet TSP-1 content in subjects with sickle cell dis...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(SICI)1096-8652(199604)51:4<296::AID-AJH8>

    authors: Browne PV,Mosher DF,Steinberg MH,Hebbel RP

    更新日期:1996-04-01 00:00:00

  • High-dose cytosine arabinoside for acute nonlymphocytic leukemia.

    abstract::Eighteen patients with acute nonlymphocytic leukemia (ANLL), aged 17-73 years, were treated with high-dose cytosine arabinoside (HD-Ara-C) using 3 g/m2 IV q 12 hours X 12 doses. Seven patients were treated for relapse and four (57%) obtained a complete remission with a median duration of 19.5 weeks. In nine patients, ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830160108

    authors: Cantin G,Brennan JK

    更新日期:1984-01-01 00:00:00

  • Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.

    abstract::Autoimmune hemolytic anemia is thought to be mediated via auto-antibodies produced by lymphoid B cells. This may be an idiopathic process or secondary to an underlying infection or lymphoproliferative disorder. Conventional treatment comprises immunosuppression with corticosteroids and, in some cases, splenectomy. A p...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.20220

    authors: Ramanathan S,Koutts J,Hertzberg MS

    更新日期:2005-02-01 00:00:00

  • Nonspecific esterase of acute promyelocytic leukemia (M3).

    abstract::Leukemic cells of 43 patients with acute promyelocytic leukemia (M3) were investigated morphologically and cytochemically to determine the percentage of aberrant enzymes and whether or not the presence impacts on the clinical outcome. Twelve patients (27.9%) showed alpha-naphthyl acetate esterase (ANAE) activity in th...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830290306

    authors: Matsuo T,Jain NC,Bennett JM

    更新日期:1988-11-01 00:00:00

  • Altered cytokine profiles in patients with Chuvash polycythemia.

    abstract::Chuvash polycythemia results from a homozygous 598C>T mutation in exon 3 of the von Hippel-Lindau (VHL) gene. This disrupts the normoxia pathway for degrading hypoxia inducible factor (HIF)-1alpha and HIF-2alpha causing altered expression of HIF-1 and HIF-2 inducible genes. As hypoxia induces expression of pro-inflamm...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21327

    authors: Niu X,Miasnikova GY,Sergueeva AI,Polyakova LA,Okhotin DJ,Tuktanov NV,Nouraie M,Ammosova T,Nekhai S,Gordeuk VR

    更新日期:2009-02-01 00:00:00

  • Splenectomy for thrombocytopenia in chronic lymphocytic leukemia.

    abstract::The role of peripheral platelet destruction as a reversible etiology of thrombocytopenia in chronic lymphocytic leukemia (CLL) was evaluated in nine patients with CLL and refractory thrombocytopenia who underwent splenectomy. The patients' ages ranged from 54 to 74 years. Progressive thrombocytopenia refractory to ant...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830150306

    authors: Merl SA,Theodorakis ME,Goldberg J,Gottlieb AJ

    更新日期:1983-11-01 00:00:00

  • HTLV-1 unrelated adult T-cell leukemia/lymphoma with unique phenotype and karyotype.

    abstract::We describe a unique case of adult T-cell leukemia/lymphoma (ATL). The patient had typical clinicohematological features as ATL, but showed a lack of antibody to human T-cell leukemia virus type-1 (HTLV-1) and was negative for HTLV-1 proviral DNA in the peripheral mononuclear cells by means of polymerase chain reactio...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(200005)64:1<64::aid-ajh11>

    authors: Nakase K,Hasegawa M,Tsuji K,Ikeda T,Tamaki S,Tanigawa M,Miyanishi E,Shiku H

    更新日期:2000-05-01 00:00:00

  • Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.

    abstract::The effect of several iron chelators on iron uptake and release by mouse peritoneal macrophages has been investigated. The 1,2-dimethyl (L1) and 1-ethyl-2-methyl (L1NEt) derivatives of 3-hydroxypyrid-4-one markedly enhanced iron mobilisation from macrophages pulsed with 59Fe-transferrin-antitransferrin immune complexe...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830340106

    authors: Brock JH,Licéaga J,Arthur HM,Kontoghiorghes GJ

    更新日期:1990-05-01 00:00:00

  • Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents.

    abstract::Several syndromes characterized by striking eosinophilia may be complicated by thrombosis. The experiments described indicate that, paradoxically, eosinophils and certain of their constituents inhibit the activation of Hageman factor (HF, factor XII). In earlier studies, suspensions of mixed types of granulocytes, oth...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830420127

    authors: Ratnoff OD,Gleich GJ,Shurin SB,Kazura J,Everson B,Embury P

    更新日期:1993-01-01 00:00:00

  • Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation.

    abstract::Total body irradiation (TBI) has been thought to promote donor cell engraftment in allogeneic hematopoietic cell transplantation (HCT) from alternative donors. However, recent progress in HCT strategies may affect the clinical significance of TBI on neutrophil engraftment. With the use of a Japanese transplant registr...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24613

    authors: Nakasone H,Fuji S,Yakushijin K,Onizuka M,Shinohara A,Ohashi K,Miyamura K,Uchida N,Takanashi M,Ichinohe T,Atsuta Y,Fukuda T,Ogata M,Complication Working Group of Japanese Society for Hematopoietic Cell Transplantation.

    更新日期:2017-02-01 00:00:00

  • Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.

    abstract::Unprecedented advances in our understanding of the pathobiology, prognostication, and therapeutic options in mantle cell lymphoma (MCL) have taken place in the last few years. Heterogeneity in the clinical course of MCL-indolent vs aggressive-is further delineated by a correlation with the mutational status of the var...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.25487

    authors: Jain P,Wang M

    更新日期:2019-06-01 00:00:00

  • AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes.

    abstract::AL amyloidosis, a systemic disorder characterized by widespread deposition of amyloid fibrils derived from monoclonal Ig light chains in organs and soft tissues, is typically caused by an underlying plasma cell dyscrasia. However, this disease can also be associated rarely with a B-cell lymphoproliferative disorder. I...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20635

    authors: Sanchorawala V,Blanchard E,Seldin DC,O'Hara C,Skinner M,Wright DG

    更新日期:2006-09-01 00:00:00

  • Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut.

    abstract::In light of the relationship between immune system dysregulation and multiple myeloma (MM) risk, we investigated whether genetic variation in 92 immune function genes among 77 gene regions are associated with MM susceptibility in a population-based case-control study (108 cases and 482 controls) conducted among Caucas...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21760

    authors: Lee KM,Baris D,Zhang Y,Hosgood HD 3rd,Menashe I,Yeager M,Zahm SH,Wang SS,Purdue MP,Chanock S,Zheng T,Rothman N,Lan Q

    更新日期:2010-08-01 00:00:00

  • Hemostatic molecular markers before the onset of disseminated intravascular coagulation.

    abstract::We retrospectively measured various hemostatic markers in 240 patients with disseminated intravascular coagulation (DIC) before the onset of DIC and in 110 non-DIC patients, and examined their usefulness for the diagnosis of pre-DIC. Changes in prothrombin time ratio and fibrinogen levels were not significant before t...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199904)60:4<273::aid-ajh4>

    authors: Wada H,Sakuragawa N,Mori Y,Takagi M,Nakasaki T,Shimura M,Hiyoyama K,Nisikawa M,Gabazza EC,Deguchi K,Kazama M,Shiku H

    更新日期:1999-04-01 00:00:00

  • The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.

    abstract::Splenectomy is a time-honoured well established approach for patients with steroid-resistant immune thrombocytopenia (ITP). However, due to the more recent availability of therapeutic options alternative to splenectomy, such as rituximab and agonists of the thrombopoietin-receptor, the choice of second-line therapy is...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23823

    authors: Palandri F,Polverelli N,Catani L,Sollazzo D,Romano M,Levorato M,Vianelli N

    更新日期:2014-11-01 00:00:00

  • Platelet interaction with bacteria. VI. contrasting the role of fibrinogen and fibronectin.

    abstract::The roles of fibrinogen and fibronectin were contasted in the responses of human platelets to Staphylococcus aureus and collagen. Congenital afibrinogenemic (CA) platelets and washed normal platelets had delayed aggregation due to a prolonged latent phase in response to contact with the bacteria when fibrinogen was ab...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830090106

    authors: Clawson CC,White JG,Herzberg MC

    更新日期:1980-01-01 00:00:00

  • A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.

    abstract::Relapsed or refractory acute myeloid leukemia (R/R AML) has a poor prognosis and is best treated with salvage chemotherapy as a bridge to allogeneic stem cell transplant (alloSCT). However, the optimal salvage therapy remains unknown. Here we compared two salvage regimens; mitoxantrone, etoposide, and cytarabine (MEC)...

    journal_title:American journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1002/ajh.25838

    authors: Christian S,Arain S,Patel P,Khan I,Calip GS,Agrawal V,Sweiss K,Griffin S,Cahill K,Konig H,Esen A,Shergill A,Odenike O,Stock W,Quigley JG

    更新日期:2020-08-01 00:00:00

  • Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.

    abstract::Non-Hodgkin lymphoma arising in the context of immunosuppression is an important adverse outcome after solid organ transplantation. Diffuse large B-cell lymphoma (DLBCL) is the most commonly diagnosed subtype of post-transplantation non-Hodgkin lymphoma, but few studies of transplant recipients have examined subtype-s...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23726

    authors: Gibson TM,Engels EA,Clarke CA,Lynch CF,Weisenburger DD,Morton LM

    更新日期:2014-07-01 00:00:00

  • Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura.

    abstract::Although treatment with plasma exchange increased the survival of patients with thrombotic thrombocytopenia purpura to 80% in the 1980s, no further increase of survival occurred over the next 20 years. However, more consistent use of adjuvant treatment with corticosteroids and rituximab in recent years has begun to fu...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.23126

    authors: George JN

    更新日期:2012-05-01 00:00:00

  • Inpatient management of sickle cell pain: a 'snapshot' of current practice.

    abstract::The Sickle Cell Disease Clinical Research Network (SCDCRN) designed the PROACTIVE Feasibility Study (ClinicalTrials.gov NCT00951808) to determine whether elevated serum levels of secretory phospholipase A2 (sPLA2) during hospitalization for pain would permit preemptive therapy of sickle cell acute chest syndrome (ACS)...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.22265

    authors: Miller ST,Kim HY,Weiner D,Wager CG,Gallagher D,Styles L,Dampier CD,Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).

    更新日期:2012-03-01 00:00:00

  • Echinocytosis--an unusual manifestation of hemangioma.

    abstract::The case of a 21 year-old female with echinocytosis and a littoral cell hemangioma is reported. The patient had no significant past medical history and presented with abdominal pain and splenomegaly. A large percentage of echinocytes were noted on her peripheral smear in the absence of any known causes. A CT-recognize...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20558

    authors: Altomare I,Desman G,Aledort LM

    更新日期:2006-07-01 00:00:00

  • Anthracycline-based therapy of de novo acute myeloid leukemia in adults: failure of first-cycle cytoreduction to predict second-cycle outcome.

    abstract::During 1971-1988, 194 adults with de novo acute myeloid leukemia (AML) received initial therapy at the University of Minnesota with an anthracycline-based regimen. Seventy-two of the 194 required further chemotherapy and received a second cycle of the same or similar therapy; 63 of these 72 were evaluable. For each ma...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830470305

    authors: Hammerschmidt DE,Crea MT

    更新日期:1994-11-01 00:00:00

  • Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.

    abstract::The optimal treatment of advanced sporadic Burkitt lymphoma in adults is still a matter of debate. The salutary results of pediatric therapies did open the road for improving the adult outcome. Between May 1988 and March 2009, 71 consecutive patients-46 adults, 25 children-affected by Burkitt lymphoma/leukemia were tr...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.22189

    authors: Todeschini G,Bonifacio M,Tecchio C,Balter R,Carli G,Stefani PM,Adami F,Zamò A,Dei Tos AP,Marino F,Gherlinzoni F,Marradi P,Semenzato G,Pizzolo G

    更新日期:2012-01-01 00:00:00

  • Reactivity of autoantibodies of autoimmune hemolytic anemia with recombinant rhesus blood group antigens or anion transporter band3.

    abstract::The specificity of autoantibodies in autoimmune hemolytic anemia (AIHA) has been studied using the serological procedure and immunoprecipitation technique with rare phenotype red cells. We attempted to analyze specificity using recombinant rhesus (Rh) blood group and band3 antigens expressed on erythroleukemic cell li...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.1161

    authors: Iwamoto S,Kamesaki T,Oyamada T,Okuda H,Kumada M,Omi T,Takahashi J,Tani Y,Omine M,Kajii E

    更新日期:2001-10-01 00:00:00

  • Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma.

    abstract::We recently defined event-free survival at 24 months (EFS24) as a clinically relevant outcome for patients with DLBCL. Patients who fail EFS24 have very poor overall survival, while those who achieve EFS24 have a subsequent overall survival equivalent to that of the age- and sex-matched general population. Here, we de...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24223

    authors: Maurer MJ,Jais JP,Ghesquières H,Witzig TE,Hong F,Haioun C,Thompson CA,Thieblemont C,Micallef IN,Porrata LF,Ribrag V,Nowakowski GS,Casasnovas O,Bologna S,Morschhauser F,Morrison VA,Peterson BA,Macon WR,Copie-Bergman C

    更新日期:2016-02-01 00:00:00